HOME >> BIOLOGY >> NEWS
Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon

The Pittsburgh NMR Center for Biomedical Research has received a five-year, $6.7 million grant from the National Institute of Biomedical Imaging and Bioengineering to pursue innovative work in applying nuclear magnetic resonance (NMR) to biomedical sciences.

The Pittsburgh NMR Center for Biomedical Research is a joint endeavor of Carnegie Mellon University and the University of Pittsburgh and is administered through the MPC Corporation. "We are very pleased to receive this grant, which will help us continue to make major contributions to the rapidly growing field of NMR in biology and medicine," said Chien Ho, director of the center and professor of Biological Sciences at Carnegie Mellon. Funds will allow investigators to pursue research in five technological research and development projects in magnetic resonance imaging (MRI), including:

  • Non-Invasive Detection of Allograft Rejection Using MRI. Organ transplantation is the preferred treatment for patients with end-stage organ failure; however, transplanted organs often fail when a patient's immune system rejects the new implant. Early diagnosis and treatment of organ rejection is critical. Center investigators are developing novel, non-invasive MRI-based methods to monitor organ function and the accumulation of immune cells at a transplanted organ. One of the center's primary goals is to establish a non-invasive, reliable and sensitive technique that not only detects acute rejection, but also correctly identifies rejection grades. With further development, such technology should help physicians detect organ rejection at early stages and also improve a patient's quality of life by reducing the number of invasive, post-transplantation tissue biopsies.
  • In-Vivo Magnetic Resonance Microscopy. Tracking the initiation and progression of autoimmune diseases such as multiple sclerosis (MS) is extremely difficult using current imaging technologies. NMR Center scientists are maki
    '"/>


Contact: Lauren Ward
wardle@andrew.cmu.edu
412-268-7761
Carnegie Mellon University
15-Mar-2004


Page: 1 2 3

Related biology news :

1. University of Pittsburgh receives $10 million grant for head and neck cancer
2. University of Pittsburgh medical center among first to implant heart assist device
3. University of Pittsburgh receives NIH funding to develop heart assist device for infants
4. University of Pittsburgh Medical Center acquires biotechnology firm Rheogene Inc.
5. Pittsburgh researchers engineer and successfully test SARS corona vaccine in animal model
6. Protein biomarkers accurately and quickly diagnose ALS, find Pittsburgh researchers
7. University of Pittsburgh scientist honored for major accomplishment in cancer research
8. Worlds largest scientific society to hold regional meeting in Pittsburgh
9. University of Pittsburgh named cooperative research center for muscular dystrophy
10. Infectious disease study findings presented by University of Pittsburgh scientists
11. University of Pittsburgh study links gynecological complaint to increased risk for herpes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 20, 2020 , ... NDA ... , a Clinical Operations executive with expertise in clinical trial planning and feasibility, ... as an Expert Consultant. Throughout his career, Mr. Movahhed has helped design and ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has ... Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a ... device attenuated the alarm sounds from patient monitors, ventilators and other bedside devices ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... , ... August 13, 2020 , ... True Terpenes ... creation of its Scientific Advisory Board (SAB) to research the medical potential of terpenes ... be enhanced when combined with terpenes. The board is focused on expanding the recently ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... Jim Corrigan, President and CEO has been named one of the 100 most ... industry sectors, PharmaVoice 100 honorees are selected based on how they have inspired ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON ... of its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines comes ... globe, requiring fast track capacity to provide patients with urgently needed vaccines and ...
Breaking Biology Technology:
Cached News: